These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1785182)

  • 41. Prospects for broadly protective influenza vaccines.
    Treanor JJ
    Vaccine; 2015 Nov; 33 Suppl 4():D39-45. PubMed ID: 26338145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
    de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quadrivalent Ann Arbor strain live-attenuated influenza vaccine.
    Toback SL; Levin MJ; Block SL; Belshe RB; Ambrose CS; Falloon J
    Expert Rev Vaccines; 2012 Nov; 11(11):1293-303. PubMed ID: 23151111
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The prophylactic efficacy of the trivalent polymer-subunit influenza vaccine Grippol (3)].
    El'shina GA; Gorbunov MA; Shervarli VI; Lonskaia NI; Khaitov RM; Nekrasov AV; Ivanova AS; Matrosovich MN; Puchkova NG; Pavlova LI; Malinovskiĭ AA
    Voen Med Zh; 1997 Feb; 318(2):47-9. PubMed ID: 9148581
    [No Abstract]   [Full Text] [Related]  

  • 45. [Immunological effectiveness of a method for simultaneous immunization against influenza using live and inactivated vaccines].
    Orlov VA; Zhilova GP; Ignat'eva GS; Malikova EV; Efremov BV
    Vopr Virusol; 1982; 27(3):271-5. PubMed ID: 7123907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Use of immunoenzyme analysis to study the immune response of persons inoculated with influenza vaccines and in convalescents].
    Kozhukhov VM; Zhilova GP; Kashkin AP; Meringova LF; Voĭtsekhovskiĭ BL
    Vopr Virusol; 1985; 30(6):745-9. PubMed ID: 3913138
    [No Abstract]   [Full Text] [Related]  

  • 47. Variability in infectivity of cold-adapted recombinant influenza virus vaccines in humans.
    Keitel WA; Couch RB; Cate TR; Maassab HF
    J Infect Dis; 1994 Feb; 169(2):477. PubMed ID: 8106789
    [No Abstract]   [Full Text] [Related]  

  • 48. Synthetic recombinant vaccine induces anti-influenza long-term immunity and cross-strain protection.
    Arnon R; Levi R
    Adv Exp Med Biol; 1996; 397():23-9. PubMed ID: 8718578
    [No Abstract]   [Full Text] [Related]  

  • 49. Dose sparing with intradermal injection of influenza vaccine.
    Kenney RT; Frech SA; Muenz LR; Villar CP; Glenn GM
    N Engl J Med; 2004 Nov; 351(22):2295-301. PubMed ID: 15525714
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced lymphoproliferation to influenza A virus following vaccination of older, chronically ill adults with live-attenuated viruses.
    Gorse GJ; Belshe RB
    Scand J Infect Dis; 1991; 23(1):7-17. PubMed ID: 2028230
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Variant-specific antihemagglutinin serum response to type A influenza natural infection and inactivated vaccines in adults.
    Kasel JA; Six HR; Couch RB; Greenberg SB; Cate TR
    Proc Soc Exp Biol Med; 1979 Sep; 161(4):519-21. PubMed ID: 90369
    [No Abstract]   [Full Text] [Related]  

  • 52. Humoral and cellular immune response to influenza virus vaccination in aged humans.
    Fagiolo U; Amadori A; Cozzi E; Bendo R; Lama M; Douglas A; Palù G
    Aging (Milano); 1993 Dec; 5(6):451-8. PubMed ID: 8161577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Humoral and local immune response to the influenza vaccine in people of old and young ages].
    Barantseva IB; Naĭkhin AN; Donina SA; Stepanova LA; Rekstin AR; Grigor'eva EP; Desheva IuA; Rudenko LG
    Vopr Virusol; 2003; 48(2):32-6. PubMed ID: 12924097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A contribution of cellular immunity to protection against influenza in man.
    Jennings R; Fenton RJ; McEntegart MG; Potter CW
    Med Microbiol Immunol; 1978 Nov; 166(1-4):51-62. PubMed ID: 723791
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors for poor immune response to influenza vaccination in elderly people.
    Bellei NC; Carraro E; Castelo A; Granato CF
    Braz J Infect Dis; 2006 Aug; 10(4):269-73. PubMed ID: 17293910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Editorial commentary: Changing epidemiology of influenza B virus.
    Glezen WP
    Clin Infect Dis; 2014 Dec; 59(11):1525-6. PubMed ID: 25139967
    [No Abstract]   [Full Text] [Related]  

  • 57. Studies on human beings inoculated with influenza vaccine and bearing HI antibody against actual prevailing strains.
    Arai A; Ohashi T; Takahashi M; Nakayama M; Takeuchi Y; Maruyama Y; Ito S; Iwaya R
    Nihon Ika Daigaku Zasshi; 1987 Apr; 54(2):200-3. PubMed ID: 3584410
    [No Abstract]   [Full Text] [Related]  

  • 58. [Effectiveness of live influenza vaccines obtained by strain recombination and passages].
    Zhilova GP; Orlov VA; Malikova EV; Kozhukhov VM
    Vopr Virusol; 1987; 32(6):675-81. PubMed ID: 3445585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins.
    Vanderven HA; Ana-Sosa-Batiz F; Jegaskanda S; Rockman S; Laurie K; Barr I; Chen W; Wines B; Hogarth PM; Lambe T; Gilbert SC; Parsons MS; Kent SJ
    EBioMedicine; 2016 Jun; 8():277-290. PubMed ID: 27428437
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A universal problem.
    Hoag H
    Nat Med; 2013 Jan; 19(1):12-4. PubMed ID: 23295998
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.